Case Report
Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department

https://doi.org/10.1016/j.ajem.2020.05.058Get rights and content

Highlights

  • COVID-19 post-infectious cytokine release syndrome is a novel disease in children.

  • This syndrome has similar features as Kawasaki Disease and Toxic Shock Syndrome.

  • Features include prolonged fever, gastrointestinal symptoms with or without rash..

  • These patients decompensate quickly and require admission to monitor for stability

Abstract

The 2019 coronavirus disease (COVID-19) has not appeared to affect children as severely as adults. However, approximately 1 month after the COVID-19 peak in New York City in April 2020, cases of children with prolonged fevers abruptly developing inflammatory shock-like states have been reported in Western Europe and the United States.

This case series describes four previously healthy children with COVID-19 infection confirmed by serologic antibody testing, but negative by nasopharyngeal RT-PCR swab, presenting to the Pediatric Emergency Department (PED) with prolonged fever (5 or more days) and abrupt onset of hemodynamic instability with elevated serologic inflammatory markers and cytokine levels (IL-6, IL-8 and TNF-α).

Emergency physicians must maintain a high clinical suspicion for this COVID-19 associated post-infectious cytokine release syndrome, with features that overlap with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS) in children with recent or current COVID-19 infection, as patients can decompensate quickly.

Abbreviations

COVID-19
2019 coronavirus disease
KD
Kawasaki Disease
TSS
Toxic Shock Syndrome
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2

Keywords

COVID-19
Children
Cytokine storm
Kawasaki Disease

Cited by (0)

View Abstract